Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus

Sodium-glucose cotransporter 2 inhibitor tofogliflozin is a new type of antidiabetic drug for individuals with type 2 diabetes mellitus (T2DM). The aim of this study was to examine in which type of individuals and/or under which conditions tofogliflozin could exert more beneficial effects on body co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamei, Shinji, Iwamoto, Masahiro, Kameyama, Miyuki, Shimoda, Masashi, Kinoshita, Tomoe, Obata, Atsushi, Kimura, Tomohiko, Hirukawa, Hidenori, Tatsumi, Fuminori, Kohara, Kenji, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817268/
https://www.ncbi.nlm.nih.gov/pubmed/29507863
http://dx.doi.org/10.1155/2018/6470137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817268/
https://www.ncbi.nlm.nih.gov/pubmed/29507863
http://dx.doi.org/10.1155/2018/6470137

Ejemplares similares